Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
about
Ischaemic conditioning: pitfalls on the path to clinical translationRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationIs there a role for ischaemic conditioning in cardiac surgery?Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats.Ischemic conditioning: the challenge of protecting the diabetic heart.Secondhand smoke exposure toxicity accelerates age-related cardiac disease in old hamstersShort-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysis.Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during CardioplegiaCardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of BloodLoss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioningLow-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.Metformin in Diabetic Patients with Heart Failure: Safe and Effective?Intrinsic cardiac ganglia and acetylcholine are important in the mechanism of ischaemic preconditioning.Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.Remote Ischemic Conditioning in Elective PCI?Platelets, diabetes and myocardial ischemia/reperfusion injury.Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation.Intracoronary insulin administered at reperfusion in a porcine model of acute coronary syndrome.Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice.Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice.The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice.Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model.Conditioning-induced cardioprotection: Aging as a confounding factor
P2860
Q27000466-B7123573-FD53-4847-A2DB-B5BD597D5F9DQ28078462-EAD11F6C-47EE-490D-B2F7-470727A2FDC0Q33605260-903B7E41-0C51-41AB-AE91-111B116D68FFQ33724132-2D78625E-79DA-43D9-8676-21219205A3ACQ34457775-097B6655-13CC-4515-B75D-75A8CB0E85D1Q35147494-50338169-7FFF-4BD1-B3E4-4A7DE030D73AQ35843019-0FF8718B-30FC-418C-9037-1E03A17354D1Q35893836-1479813F-DF8A-4B2A-9FCA-1331CA214B8BQ36259660-F2F74238-5BA4-4002-A2B1-61E9815DEA38Q37022039-6A20F6BA-BD7B-4BA9-87CD-1DB82F307F20Q37034247-7DE31C15-726E-494A-942E-7E59C38DD1F1Q37056996-2F269554-CFDF-4C72-8518-836054173155Q37508043-F48DB646-617C-4D55-B674-4688140505EFQ37586119-94AF98A3-AE9B-4D4C-8B79-E1089CFD1C6BQ38903618-3ED7E5D4-E11B-4097-B999-8B694A1A294EQ39219871-1414E5D1-7528-469B-9042-B828913C1A4AQ39343342-E4624676-C655-42F1-8092-FD66F9F12E5AQ44763054-6F2D586E-E8AA-4CDD-B9FE-40A3CAEE791CQ46034115-1C9AF73B-7851-410D-9035-0CEEEC6CB959Q46146090-66ACA679-E6D1-4DE6-9EFB-595F30274D42Q50222803-A8A394EA-D508-442A-B6A1-E8656F489056Q53629285-AD68ADC6-C2CB-4719-A765-AF5E0842B0FFQ53701593-C98BFA32-1218-4143-B087-E103CF557084Q55069411-EEA9B766-FD3C-467F-AA3B-C157BBC72F72Q55365398-853EDE85-EC47-4E2D-8713-5DF40245B7C0Q58700982-BB404DCE-E472-4465-976D-BFEE1B707B34
P2860
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
@en
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
@nl
type
label
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
@en
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
@nl
prefLabel
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
@en
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
@nl
P2093
P2860
P50
P356
P1476
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling
@en
P2093
Clemency I M Stephenson
Hannah J Whittington
Idris Harding
Robert Bell
P2860
P304
P356
10.1093/CVR/CVT140
P577
2013-05-30T00:00:00Z